Sequenom Inc (SQNM) 3.67 $SQNM
Hawaiian Electric and Taser are big market movers
AP - 2 hrs 23 mins ago
NEW YORK (AP) — Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and the Nasdaq Stock Market:
TSLA: 228.28 (-1.02), HE: 32.22 (+4.03), PLUG: 3.70 (+0.20), CLV: 7.55 (-0.60), CLF: 8.03 (-0.57), BKS: 21.03 (-1.21), ARO: 2.48 (-0.71), RAD: 5.58 (+0.12), CARB: 14.21 (-0.23), SQNM: 3.67 (-0.10), ENB.TO: 60.04 (+5.61), RIG: 18.68 (-0.89), IDRA: 4.06 (-0.01), ANF: 27.90 (-0.91), ENB: 52.80 (+4.92), TASR: 24.15 (+1.29), AVGO: 103.07 (+7.94), PBYI: 195.55 (-2.12)
Is Sequenom Next?
Doug Van Cuyk - at Seeking Alpha - Thu Dec 04, 1:37PM CST
SQNM: 3.67 (-0.10)
Most active Nasdaq-traded stocks
AP - Thu Dec 04, 12:49PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at 1 p.m.:
MU: 36.07 (-0.03), SQNM: 3.67 (-0.10), PLUG: 3.70 (+0.20), FB: 75.24 (+0.36), AMAT: 24.40 (-0.18), JBLU: 15.09 (+0.27), MSFT: 48.84 (+0.76), INTC: 37.46 (+0.03), AAPL: 115.49 (-0.44), CSCO: 27.77 (-0.18), RFMD: 15.53 (+0.52)
Sequenom (SQNM) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 04, 8:08AM CST
Sequenom (SQNM) Shares March Higher, Can It Continue?
SQNM: 3.67 (-0.10)
Sequenom Inc. (SQNM) in Focus: Stock Surges 23.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 04, 6:21AM CST
Sequenom Inc. (SQNM) was a big mover last session, as the company saw its shares rise by nearly 24% on the day.
BIIB: 341.18 (-6.16), SQNM: 3.67 (-0.10), ANIP: 53.45 (-6.76), AFFX: 9.14 (-0.04)
Stocks Close Higher, Helped by Continued Strength in Economy
at The Street - Wed Dec 03, 3:19PM CST
The S&P 500 inched to another record high Wednesday after the release of the Federal Reserve's Beige Book showed the economy is still gaining strength.
GIII: 96.10 (-0.68), HAL: 40.74 (-0.01), BOBE: 50.21 (+2.30), ILMN: 190.83 (-0.42), SLB: 87.43 (+0.67), SQNM: 3.67 (-0.10), JCP: 6.73 (-0.46), BP: 40.39 (-0.92), PBYI: 195.55 (-2.12), XLE: 81.25 (-0.71)
Why Sequenom, Inc. Stock Skyrocketed
Sean Williams, The Motley Fool - Motley Fool - Wed Dec 03, 2:44PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Sequenom , a developer of genetic analysis...
SQNM: 3.67 (-0.10), ILMN: 190.83 (-0.42)
S&P 500 in Range of Record Highs as Fed Says Consumers Spending More
at The Street - Wed Dec 03, 2:30PM CST
U.S. stocks are trading just shy of record highs on Wednesday as energy stocks lead gainers and shake off recent tumbling commodity prices.
SQNM: 3.67 (-0.10), JCP: 6.73 (-0.46), HAL: 40.74 (-0.01), GIII: 96.10 (-0.68), ILMN: 190.83 (-0.42), BP: 40.39 (-0.92), SLB: 87.43 (+0.67), XLE: 81.25 (-0.71)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Dec 03, 11:45AM CST
GLOG: 18.49 (-0.13), MILL: 1.67 (-0.13), LPHI: 1.06 (-0.04), NEOT: 8.70 (-0.05), BOBE: 50.21 (+2.30), FES: 1.53 (-0.18), REDF: 2.37 (-0.06), NKTR: 15.96 (+0.20), PRTO: 9.05 (+0.04), CANF: 4.04 (-0.23), CALI: 1.46 (+0.02), TRT: 3.22 (-0.03), SQNM: 3.67 (-0.10), CARB: 14.21 (-0.23), SEED: 1.28 (-0.12), BLFS: 1.80 (-0.04), DGLY: 21.00 (+3.08), TCCO: 5.37 (-0.76), ALCO: 40.47 (-0.43), PBYI: 195.55 (-2.12)
Sequenom (SQNM) Stock Spikes Following NIPT Patent Settlement With Illumina
at The Street - Wed Dec 03, 11:14AM CST
Sequenom (SQNM) shares are up after the company settled its patent dispute with rival Illumina (ILMN) today.
SQNM: 3.67 (-0.10)
Stock to Watch: Sequenom Up 24.9% (SQNM)
Comtex SmarTrend(R) - Wed Dec 03, 10:07AM CST
Sequenom (NASDAQ:SQNM) is one of today's best performing low-priced stocks, up 24.9% to $3.81 on 7.0x average daily volume. Thus far today, Sequenom has traded 10.3 million shares, vs. average volume of 1.5 million shares per day. The stock has outperformed the Dow (24.9% to the Dow's 0.1%) and outperformed the S&P 500 (24.9% to the S&P's 0.2%) during today's trading.
SQNM: 3.67 (-0.10)
Sequenom climbs as Illumina patent dispute ends
AP - Wed Dec 03, 9:58AM CST
NEW YORK (AP) — Shares of Sequenom surged Wednesday after the genetic analysis company said it resolved a patent dispute over prenatal testing products with competitor Illumina.
SQNM: 3.67 (-0.10), ILMN: 190.83 (-0.42)
Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Dec 03, 8:09AM CST
MOLG: 2.85 (-1.05), SQNM: 3.67 (-0.10), JCP: 6.73 (-0.46), NTLS: 4.56 (+0.01), PBYI: 195.55 (-2.12)
Time to Focus on Sequenom (SQNM) for Strong Earnings Growth Potential - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 7:32AM CST
Sequenom (SQNM) might be well-positioned for future earnings growth. This firm saw EPS growth of 14.6% last year, and is looking great for this year too. The current growth estimate for this year calls for earnings-per-share growth of 66.4%.
SQNM: 3.67 (-0.10)
Ilumina and Sequenom settle patent infringement claims
Seeking Alpha - at Seeking Alpha - Wed Dec 03, 6:57AM CST
SQNM: 3.67 (-0.10), ILMN: 190.83 (-0.42)
Illumina and Sequenom Pool Noninvasive Prenatal Testing Intellectual Property and End Outstanding Patent Disputes
Business Wire - Wed Dec 03, 5:00AM CST
Illumina, Inc. (NASDAQ: ILMN) and Sequenom, Inc. (NASDAQ: SQNM) today announced they have agreed to settle all pending infringement claims and other disputes between Sequenom and Verinata Health, Inc. The parties will pool their owned and in-licensed intellectual property directed to noninvasive prenatal testing (NIPT), including patents that will remain the subject of ongoing interference proceedings.
SQNM: 3.67 (-0.10), ILMN: 190.83 (-0.42)
Life Sciences Tools and Services Equities Ahead of Market - Sequenom, Illumina, PerkinElmer, Affymetrix, and Waters
PR Newswire - Wed Nov 26, 8:00AM CST
Investor-Edge has initiated coverage on the following equities: Sequenom Inc. (NASDAQ: SQNM), Illumina Inc. (NASDAQ: ILMN), PerkinElmer Inc. (NYSE: PKI), Affymetrix Inc. (NASDAQ: AFFX), and Waters Corporation (NYSE: WAT). Free research on these five companies can be accessed at:http://investor-edge.com/register. The US markets on Tuesday, November 25, 2014, ended on a mixed note as the Dow Jones Industrial Average finished at 17,814.94, down 0.02% and the NASDAQ Composite closed at 4,758.25, up 0.07%. The S&P 500 finished the session 0.12% lower at 2,067.03. During the trading session, five out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 793.40, up 0.07%, with the index advancing 8.30% in the previous three months. Register for your complimentary reports on these five stocks at:
SQNM: 3.67 (-0.10), ILMN: 190.83 (-0.42), PKI: 44.55 (-0.30), WAT: 116.49 (-0.49), AFFX: 9.14 (-0.04)
Sequenom, Inc. Announces Participation At The 26th Annual Piper Jaffray Healthcare Conference
PR Newswire - Tue Nov 25, 6:00AM CST
Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced the Company's participation at the 2014 Piper Jaffray Healthcare Conference at the New York Palace Hotel in New York, NY on December 2-3, 2014.
SQNM: 3.67 (-0.10)
2014-2014 UK Hepatitis Markers Testing Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures
M2 - Mon Nov 24, 10:25AM CST
Research and Markets (http://www.researchandmarkets.com/research/swvhm8/20142014_uk) has announced the addition of the "2014-2014 UK Hepatitis Markers Testing Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures" report to their offering. The report presents a detailed analysis of the Hepatitis diagnostics market in the UK. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets: - Hospitals - Commercial/Private Labs - Blood Banks In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns. Key Topics Covered: - INTRODUCTION - HEPATITIS WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW - UK: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES - POTENTIAL MARKET ENTRY BARRIERS AND RISKS - COMPETITIVE ASSESSMENTS - Abbott - Affymetrix - Beckman Coulter/Danaher - Becton Dickinson - bioMerieux - Bio-Rad - Cepheid - Diamedix - DiaSorin - Eiken Chemical - Enzo Biochem - Fujirebio/Innogenetics - Hologic/Gen-Probe - ID Biomedical/GSK - Kreatech - Life Technology - Lonza - Nanogen/Elitech - Novartis Diagnostics/Grifols - Ortho-Clinical Diagnostics - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Takara Bio - Thermo Fisher - Wallac/PE - Wako For more information visit http://www.researchandmarkets.com/research/sw...0142014_uk
SQNM: 3.67 (-0.10), ENZ: 4.56 (-0.05), CPHD: 53.37 (-0.13), DHR: 84.58 (-0.27), HOLX: 26.52 (-0.11), NVS: 95.77 (+0.11)
Sequenom Has Taken All The Right Steps To Reach Profitability
Doug Van Cuyk - at Seeking Alpha - Thu Nov 06, 3:09PM CST
SQNM: 3.67 (-0.10)
Hawaiian Electric and Taser are big market movers
AP - 2 hrs 23 mins ago
NEW YORK (AP) — Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and the Nasdaq Stock Market:
TSLA: 228.28 (-1.02), HE: 32.22 (+4.03), PLUG: 3.70 (+0.20), CLV: 7.55 (-0.60), CLF: 8.03 (-0.57), BKS: 21.03 (-1.21), ARO: 2.48 (-0.71), RAD: 5.58 (+0.12), CARB: 14.21 (-0.23), SQNM: 3.67 (-0.10), ENB.TO: 60.04 (+5.61), RIG: 18.68 (-0.89), IDRA: 4.06 (-0.01), ANF: 27.90 (-0.91), ENB: 52.80 (+4.92), TASR: 24.15 (+1.29), AVGO: 103.07 (+7.94), PBYI: 195.55 (-2.12)
Is Sequenom Next?
Doug Van Cuyk - at Seeking Alpha - Thu Dec 04, 1:37PM CST
SQNM: 3.67 (-0.10)
Most active Nasdaq-traded stocks
AP - Thu Dec 04, 12:49PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at 1 p.m.:
MU: 36.07 (-0.03), SQNM: 3.67 (-0.10), PLUG: 3.70 (+0.20), FB: 75.24 (+0.36), AMAT: 24.40 (-0.18), JBLU: 15.09 (+0.27), MSFT: 48.84 (+0.76), INTC: 37.46 (+0.03), AAPL: 115.49 (-0.44), CSCO: 27.77 (-0.18), RFMD: 15.53 (+0.52)
Sequenom (SQNM) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 04, 8:08AM CST
Sequenom (SQNM) Shares March Higher, Can It Continue?
SQNM: 3.67 (-0.10)
Sequenom Inc. (SQNM) in Focus: Stock Surges 23.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 04, 6:21AM CST
Sequenom Inc. (SQNM) was a big mover last session, as the company saw its shares rise by nearly 24% on the day.
BIIB: 341.18 (-6.16), SQNM: 3.67 (-0.10), ANIP: 53.45 (-6.76), AFFX: 9.14 (-0.04)
Stocks Close Higher, Helped by Continued Strength in Economy
at The Street - Wed Dec 03, 3:19PM CST
The S&P 500 inched to another record high Wednesday after the release of the Federal Reserve's Beige Book showed the economy is still gaining strength.
GIII: 96.10 (-0.68), HAL: 40.74 (-0.01), BOBE: 50.21 (+2.30), ILMN: 190.83 (-0.42), SLB: 87.43 (+0.67), SQNM: 3.67 (-0.10), JCP: 6.73 (-0.46), BP: 40.39 (-0.92), PBYI: 195.55 (-2.12), XLE: 81.25 (-0.71)
Why Sequenom, Inc. Stock Skyrocketed
Sean Williams, The Motley Fool - Motley Fool - Wed Dec 03, 2:44PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Sequenom , a developer of genetic analysis...
SQNM: 3.67 (-0.10), ILMN: 190.83 (-0.42)
S&P 500 in Range of Record Highs as Fed Says Consumers Spending More
at The Street - Wed Dec 03, 2:30PM CST
U.S. stocks are trading just shy of record highs on Wednesday as energy stocks lead gainers and shake off recent tumbling commodity prices.
SQNM: 3.67 (-0.10), JCP: 6.73 (-0.46), HAL: 40.74 (-0.01), GIII: 96.10 (-0.68), ILMN: 190.83 (-0.42), BP: 40.39 (-0.92), SLB: 87.43 (+0.67), XLE: 81.25 (-0.71)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Dec 03, 11:45AM CST
GLOG: 18.49 (-0.13), MILL: 1.67 (-0.13), LPHI: 1.06 (-0.04), NEOT: 8.70 (-0.05), BOBE: 50.21 (+2.30), FES: 1.53 (-0.18), REDF: 2.37 (-0.06), NKTR: 15.96 (+0.20), PRTO: 9.05 (+0.04), CANF: 4.04 (-0.23), CALI: 1.46 (+0.02), TRT: 3.22 (-0.03), SQNM: 3.67 (-0.10), CARB: 14.21 (-0.23), SEED: 1.28 (-0.12), BLFS: 1.80 (-0.04), DGLY: 21.00 (+3.08), TCCO: 5.37 (-0.76), ALCO: 40.47 (-0.43), PBYI: 195.55 (-2.12)
Sequenom (SQNM) Stock Spikes Following NIPT Patent Settlement With Illumina
at The Street - Wed Dec 03, 11:14AM CST
Sequenom (SQNM) shares are up after the company settled its patent dispute with rival Illumina (ILMN) today.
SQNM: 3.67 (-0.10)
Stock to Watch: Sequenom Up 24.9% (SQNM)
Comtex SmarTrend(R) - Wed Dec 03, 10:07AM CST
Sequenom (NASDAQ:SQNM) is one of today's best performing low-priced stocks, up 24.9% to $3.81 on 7.0x average daily volume. Thus far today, Sequenom has traded 10.3 million shares, vs. average volume of 1.5 million shares per day. The stock has outperformed the Dow (24.9% to the Dow's 0.1%) and outperformed the S&P 500 (24.9% to the S&P's 0.2%) during today's trading.
SQNM: 3.67 (-0.10)
Sequenom climbs as Illumina patent dispute ends
AP - Wed Dec 03, 9:58AM CST
NEW YORK (AP) — Shares of Sequenom surged Wednesday after the genetic analysis company said it resolved a patent dispute over prenatal testing products with competitor Illumina.
SQNM: 3.67 (-0.10), ILMN: 190.83 (-0.42)
Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Dec 03, 8:09AM CST
MOLG: 2.85 (-1.05), SQNM: 3.67 (-0.10), JCP: 6.73 (-0.46), NTLS: 4.56 (+0.01), PBYI: 195.55 (-2.12)
Time to Focus on Sequenom (SQNM) for Strong Earnings Growth Potential - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 7:32AM CST
Sequenom (SQNM) might be well-positioned for future earnings growth. This firm saw EPS growth of 14.6% last year, and is looking great for this year too. The current growth estimate for this year calls for earnings-per-share growth of 66.4%.
SQNM: 3.67 (-0.10)
Ilumina and Sequenom settle patent infringement claims
Seeking Alpha - at Seeking Alpha - Wed Dec 03, 6:57AM CST
SQNM: 3.67 (-0.10), ILMN: 190.83 (-0.42)
Illumina and Sequenom Pool Noninvasive Prenatal Testing Intellectual Property and End Outstanding Patent Disputes
Business Wire - Wed Dec 03, 5:00AM CST
Illumina, Inc. (NASDAQ: ILMN) and Sequenom, Inc. (NASDAQ: SQNM) today announced they have agreed to settle all pending infringement claims and other disputes between Sequenom and Verinata Health, Inc. The parties will pool their owned and in-licensed intellectual property directed to noninvasive prenatal testing (NIPT), including patents that will remain the subject of ongoing interference proceedings.
SQNM: 3.67 (-0.10), ILMN: 190.83 (-0.42)
Life Sciences Tools and Services Equities Ahead of Market - Sequenom, Illumina, PerkinElmer, Affymetrix, and Waters
PR Newswire - Wed Nov 26, 8:00AM CST
Investor-Edge has initiated coverage on the following equities: Sequenom Inc. (NASDAQ: SQNM), Illumina Inc. (NASDAQ: ILMN), PerkinElmer Inc. (NYSE: PKI), Affymetrix Inc. (NASDAQ: AFFX), and Waters Corporation (NYSE: WAT). Free research on these five companies can be accessed at:http://investor-edge.com/register. The US markets on Tuesday, November 25, 2014, ended on a mixed note as the Dow Jones Industrial Average finished at 17,814.94, down 0.02% and the NASDAQ Composite closed at 4,758.25, up 0.07%. The S&P 500 finished the session 0.12% lower at 2,067.03. During the trading session, five out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 793.40, up 0.07%, with the index advancing 8.30% in the previous three months. Register for your complimentary reports on these five stocks at:
SQNM: 3.67 (-0.10), ILMN: 190.83 (-0.42), PKI: 44.55 (-0.30), WAT: 116.49 (-0.49), AFFX: 9.14 (-0.04)
Sequenom, Inc. Announces Participation At The 26th Annual Piper Jaffray Healthcare Conference
PR Newswire - Tue Nov 25, 6:00AM CST
Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced the Company's participation at the 2014 Piper Jaffray Healthcare Conference at the New York Palace Hotel in New York, NY on December 2-3, 2014.
SQNM: 3.67 (-0.10)
2014-2014 UK Hepatitis Markers Testing Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures
M2 - Mon Nov 24, 10:25AM CST
Research and Markets (http://www.researchandmarkets.com/research/swvhm8/20142014_uk) has announced the addition of the "2014-2014 UK Hepatitis Markers Testing Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures" report to their offering. The report presents a detailed analysis of the Hepatitis diagnostics market in the UK. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets: - Hospitals - Commercial/Private Labs - Blood Banks In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns. Key Topics Covered: - INTRODUCTION - HEPATITIS WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW - UK: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES - POTENTIAL MARKET ENTRY BARRIERS AND RISKS - COMPETITIVE ASSESSMENTS - Abbott - Affymetrix - Beckman Coulter/Danaher - Becton Dickinson - bioMerieux - Bio-Rad - Cepheid - Diamedix - DiaSorin - Eiken Chemical - Enzo Biochem - Fujirebio/Innogenetics - Hologic/Gen-Probe - ID Biomedical/GSK - Kreatech - Life Technology - Lonza - Nanogen/Elitech - Novartis Diagnostics/Grifols - Ortho-Clinical Diagnostics - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Takara Bio - Thermo Fisher - Wallac/PE - Wako For more information visit http://www.researchandmarkets.com/research/sw...0142014_uk
SQNM: 3.67 (-0.10), ENZ: 4.56 (-0.05), CPHD: 53.37 (-0.13), DHR: 84.58 (-0.27), HOLX: 26.52 (-0.11), NVS: 95.77 (+0.11)
Sequenom Has Taken All The Right Steps To Reach Profitability
Doug Van Cuyk - at Seeking Alpha - Thu Nov 06, 3:09PM CST
SQNM: 3.67 (-0.10)
